Influence of CD151 Inhibition by RNAi on Lung Metastasis in Null Mice Given Tail Veins Injection of Lung Adenocarcinoma Cell Lines A549

Hu Feng Di; Zhang Jian Qiang; Wang Chu; Luo Chun Xiang; Li Ke

Volume 39 Issue 04

Turn off MathJax

Article Contents

Abstract

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2018 > 39(04): 21-26

Wang Yan , Li Xiu Fang , He Li Ping , Dai Da Chun , Yang Gui Yun , Tang Ming . The Application of Modified Pediatric Early Warning Score in Emergency Medical Treatment and Classification[J]. Journal of Kunming Medical University, 2018, 39(08): 69-73.

Citation:

Hu Feng Di , Zhang Jian Qiang , Wang Chu , Luo Chun Xiang , Li Ke . Influence of CD151 Inhibition by RNAi on Lung Metastasis in Null Mice Given Tail Veins Injection of Lung Adenocarcinoma Cell Lines A549[J]. Journal of Kunming Medical University, 2018, 39(04): 21-26.

Citation:

PDF( 2546 KB)

Influence of CD151 Inhibition by RNAi on Lung Metastasis in Null Mice Given Tail Veins Injection of Lung Adenocarcinoma Cell Lines A549

Funds:

基金：云南省教育厅科学研究基金资助项目 (2015Y181); 云南省肿瘤医院博士科研基金资助项目 (BSJJ201506); 普洱学院校级创新团队基金资助项目 (CXTD) ;普洱学院高层次人才科研启动基金资助项目 (K2017051);

Received Date: 2017-09-09

Abstract

Abstract

Objective To explore the influence of CD151 inhibition by RNA interference on lung metastasis in null mice given tail veins injection of lung adenocarcinoma cell lines A549. METHODS: Constructed CD151 inhibition by RNA interference cell lines A549-sh RNA, A549-sh NC and A549-Blank were injected into the tail veins of BALB/c nude mice. Lung metastasis was measured through naked eye and pathology of HE stain. Re s ults Lung metastasis were 62.5% (5/8) and (4.7±1.5) , 100% (7/7) and (9.3±0.8) , 75% (6/8) and (8.2±1.5) , respectively in A549-sh RNA, A549-sh NC and A549-Blank. There were differences between A549-sh RNA and A549-sh NC (P = 0.000) and between A549-sh RNA and A549-Blank (P = 0.006) .Conclus ions Inhibition of CD151 gene expression can reduce lung metastasis in null mice given tail veins injection of lung adenocarcinoma cell lines A549. CD151 may become one of the potential therapeutic targets aiming at inhibitung invasion and metastasis of NSCLC.
- CD151,
- Non-small cell lung cancer,
- BALB/c-nude mice,
- Lung metastasis

FullText(HTML)

References(12)

References

[1]石远凯, 孙燕, 于金明, 等.中国晚期原发性肺癌诊治专家共识 (2016年版) [J].中国肺癌杂志, 2016, 18 (01) :1-15.
[2]	[2]SADEJ R, GRUDOWSKA A, TURCZYK L, et al.CD151in cancer progression and metastasis:A complex scenario[J].Lab Invest, 2014, 94 (1) :41-51.
[3]李科, 洪志鹏, 李云霞, 等.非小细胞肺癌组织CD151蛋白表达临床意义探讨[J].中华肿瘤防治杂志, 2014, 22 (01) :34-38.
[4]李科, 洪志鹏, 沈丽达, 等.CD_ (151) 及整合素α_3β_1蛋白在非小细胞肺癌中的表达及意义[J].中国全科医学, 2014, 16 (05) :531-535.
[5]	[5]LI P, ZENG H, QIN J, et al.Effects of tetraspanin CD151inhibition on A549 human lung adenocarcinoma cells[J].Mol Med Rep, 2015, 11 (2) :1258-1265.
[6]	[6]KUMARI S, DEVI G T, BADANA A, et al.CD151-A Striking Marker for Cancer Therapy[J].Biomark Cancer, 2015, 22 (7) :7-11.
[7]	[7]LIU T, WANG S, WANG L, et al.Targeting CD151 by lentivirus-mediated RNA interference inhibits luminal and basal-like breast cancer cell growth and invasion[J].Mol Cell Biochem, 2015, 407 (1-2) :111-121.
[8]	[8]ZHANG Z, WANG F, LI Q, et al.CD151 knockdown inhibits osteosarcoma metastasis through the GSK-3beta/beta-catenin/MMP9 pathway[J].Oncol Rep, 2016, 35 (3) :1764-1770.
[9]	[9] AZNAVOORIAN S, MURPHY A N, STETLERSTEVENSON W G, et al.Molecular aspects of tumor cell invasion and metastasis[J].Cancer, 1993, 71 (4) :1368-1383.
[10]	[10]FIDLER I J.Critical determinants of metastasis[J].Semin Cancer Biol, 2002, 12 (2) :89-96.
[11]	[11]TAKEDA Y, LI Q, KAZAROV A R, et al.Diminished metastasis in tetraspanin CD151-knockout mice[J].Blood, 2011, 118 (2) :464-472.
[12]	[12]COPELAND B T, BOWMAN MJ, ASHMAN L K.Genetic ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate cancer in the TRAMP model[J].Mol Cancer Res, 2013, 11 (1) :95-105.

Relative Articles(20)

Relative Articles

[1]	Shengxi YANG, Jiade ZHU, Qiurui LI, Wenlian TU. Clinical Study of Aumolertinib Versus Osimertinib in the Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer. Journal of Kunming Medical University, 2025, 46(5): 1-7.
[2]	Yingfu LI, Ni GUO, Zhengguang LUO, Anhao XING, Taifu LI, Qianli MA. Correlation of EGFR Gene Polymorphisms with Non-small Cell Lung Cancer in Yunnan Han Population. Journal of Kunming Medical University, 2025, 46(): 1-10.
[3]	Huimin YU, Xin XIN, Zhiwei LIANG. Predictive Value of KIAA1199 and Linc00673 Genes on Chemotherapy Efficacy in Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2025, 46(1): 111-116. doi: 10.12259/j.issn.2095-610X.S20250115
[4]	Caini ZHANG, Ya LI. A Meta-analysis of the Efficacy and Safety of Camrelizumab Combined with Chemotherapy in the Treatment of Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2024, 45(6): 75-84. doi: 10.12259/j.issn.2095-610X.S20240610
[5]	Chao HONG, Xudong XIANG, Yingfu LI, Yang CAO, Xueya CHEN, Shuai LI, Anhao XING, Mu LIN, Qianli MA. Association of Polymorphisms in the 3' UTR of Genes in the ERK1/2 Signaling Pathway with Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2024, 45(3): 7-17. doi: 10.12259/j.issn.2095-610X.S20240302
[6]	Yan LIANG, Lei WANG, Ming LEI, Benchao CHEN, Ping SUN, Shuai LI, Li LIU, Qianrong WANG, Manlin LIAO, Qianli MA. Correlation between KRAS Gene Polymorphism and Non-small Cell Lung Cancer in Yunnan Han Population. Journal of Kunming Medical University, 2023, 44(2): 52-60. doi: 10.12259/j.issn.2095-610X.S20230210
[7]	Chuntao LI, Xuemei ZHANG, Yandi SU, Jianqing Zhang. Construction of Stable Transfected Cell Line A549 of Non-small Cell Lung Cancer by Overexpressing and Knocking Down LncRNA RP11-521C20.3. Journal of Kunming Medical University, 2023, 44(10): 1-9. doi: 10.12259/j.issn.2095-610X.S20231016
[8]	Jia YANG, Ya-xian LI, Ying-ying WANG, Lin XIAO, Chuan-yin LI, Fang TAN, Qian-li MA, Shu-yuan LIU. Association of the miR-149,miR-219 and miR-let-7 Polymorphisms with the Occurrence and Development of Non-small Cell Lung Cancer in a Chinese Han Population in Yunnan Province. Journal of Kunming Medical University, 2021, 42(10): 22-28. doi: 10.12259/j.issn.2095-610X.S20211037
[9]	Ying-xia WANG, Qin HE, Guo-fang WANG, Xuan ZHANG. Expression and Significance of microRNA-21 and EGFR in Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2021, 42(8): 101-105. doi: 10.12259/j.issn.2095-610X.S20210818
[10]	Chen Ben Chao , Li Heng , Liu Chao , Wang Shu Ting , Li Gao Feng . . Journal of Kunming Medical University, 2020, 41(06): 23-27.
[11]	Wang Juan , Su Guo Miao , Pan Guo Qing , Bian Li , Yang Zhe , Zeng Ding Tao . . Journal of Kunming Medical University, 2020, 41(09): 1-6.
[12]	Xiao-biao MA, Feng LUO, Yong-liang GAO, Jing-chao HAO. Clinical Study of Chemotherapy Combined with CIK Cell Immunotherapy for Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2020, 41(12): 60-67. doi: 10.12259/j.issn.2095-610X.S20201215
[13]	Tang Shi Cong , Pan Hong , Huang Yao Yuan , Zhou Xin , Wang Shou Feng , Zuo Chuan Tian , Mao Nai Quan . . Journal of Kunming Medical University, 2017, 38(02): 28-32.
[14]	Chen Yan Jin . . Journal of Kunming Medical University,
[15]	Zhou JieYan . . Journal of Kunming Medical University,
[16]	. Thoracoscopic Lobectomy in the Treatment of 54 Patients with Non-small Cell Lung Cancer. Journal of Kunming Medical University,
[17]	. Relationship between Expression of CDK2 and p27kip1 Protein and Non-small Cell Lung Cancer in Xuanwei. Journal of Kunming Medical University,
[18]	. Clinical Effects of Double-way Chemotherapy on Non-small Cell Lung Cancer with Malignant Pericardial Effusion. Journal of Kunming Medical University,
[19]	Yang Fang . . Journal of Kunming Medical University,
[20]	Zhang Lan Feng . . Journal of Kunming Medical University,

Supplements(0)

Cited By

Cited by

Periodical cited type(19)

1.	刘思雨，卞超凡，魏玮，王苇. 急诊分诊流程再造在儿科患者中的应用研究. 临床研究. 2023(03): 145-147 .
2.	陈宝英，周玲，李豪，梁惠冰. 儿童早期预警评分在临床护理中的应用现状. 吉林医学. 2022(01): 248-250 .
3.	赵芸，吴雪芳，韩丹枫. 急诊预检分诊评分系统在儿科急诊患者病情评估中的应用价值. 国际护理学杂志. 2022(02): 193-196 .
4.	樊月红. 循环-呼吸-腹部-运动-语言评分法在车祸成批伤患者护士预检分诊中的应用. 基层医学论坛. 2022(15): 49-51 .
5.	程君，蒋云秀，杨施展. 预警护理联合气道护理在支原体肺炎患儿中的应用效果. 中国当代医药. 2022(14): 171-174 .
6.	郑玉婷，廖云姗，范娜，潘雯滢，郑文娟，韩亚娟. 互联网技术在儿童传染病分诊防控中的应用研究. 昆明医科大学学报. 2022(06): 122-126 . 本站查看
7.	闻玲云，李姣. 改良早期预警评分分级干预在重症肺炎患儿中的应用效果. 河南医学研究. 2022(05): 919-922 .
8.	马晓园. 急诊预检分诊护理流程在危重症患者中的应用价值. 护理实践与研究. 2022(16): 2516-2519 .
9.	张宇婧，王梅珑，郝洪丽，王嘉莉，杨颖. 儿童早期预警评分结合PDCA循环在门诊手足口病患儿分诊、病情评估中的应用. 中国医药导报. 2022(22): 189-192 .
10.	何家伟，赖碧娟. 分级就诊在急诊儿内科的应用体会. 中国继续医学教育. 2021(14): 110-114 .
11.	常廷榆，孙凤玲. 儿童早期预警评分在患儿高危识别中的应用. 中国继续医学教育. 2021(22): 176-178 .
12.	李翠彤，黄玉芬，向宇俊. 儿科危急重症患儿急诊预检分诊系统的应用效果分析. 中国妇幼保健. 2021(17): 4087-4089 .
13.	贾本君，郑运凤. 改良早期预警评分在急诊预检分诊中的效果评价. 中国继续医学教育. 2020(01): 75-77 .
14.	林园如. 改良早期预警评分在急诊科患儿中的实施效果研究. 中外医学研究. 2020(04): 167-169 .
15.	张豪杰，方静文. PQRST联合儿童早期预警评分对急诊患儿预检分诊效率及护理满意度的影响. 全科护理. 2020(11): 1366-1368 .
16.	李会娜，安红，高洁林，赵英免，王晓雪. 改良儿童早期预警评分在病毒性脑炎患儿病情判断中的有效性. 临床与病理杂志. 2020(07): 1740-1743 .
17.	凌芳. 基于儿童早期预警评分的护理干预在急诊留观室危重患儿中运用效果观察. 全科护理. 2019(21): 2594-2597 .
18.	宣巧珺. 改良智能化急诊分级分诊系统的应用. 中医药管理杂志. 2019(18): 56-57 .
19.	叶靓，卢华萍. 儿童早期预警评分在危重呼吸系统疾病住院患儿护理中的应用. 重庆医学. 2019(19): 3321-3324 .